title: Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.
abstract: BACKGROUND
  Lipoatrophic diabetes is an insulin resistance syndrome characterized by the complete or partial lack of adipose tissue and disturbances in lipid and glucose metabolism. Nonalcoholic steatohepatitis (NASH) is a well-described change in liver pathology consisting of steatosis, hepatitis, and fibrosis that can be associated with lipoatrophic diabetes.
  
  
  RESULTS
  This article describes the first reported case of lipoatrophic diabetes with NASH leading to liver failure and liver transplantation. Before transplantation, the patient required 600-700 U of insulin/day. After transplantation, a dramatic decline in her insulin requirements was observed, despite corticosteroids. Eighteen months after transplantation, her glycemic control worsened, and she developed recurrent NASH on serial liver biopsies.
  
  
  CONCLUSIONS
  NASH associated with lipoatrophic diabetes can recur after liver transplantation, and in this case, was accompanied by increased insulin requirements. These results suggest that the development of NASH itself may contribute to the insulin resistance observed in lipoatrophic diabetes.
authors.affiliation: Department of Internal Medicine, University of Nebraska Medical Center, Omaha 63198-3020, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: Cauble
authors.forename: R
authors.initials: R
authors.lastname: Gilroy
authors.forename: M F
authors.initials: MF
authors.lastname: Sorrell
authors.forename: M E
authors.initials: ME
authors.lastname: Mailliard
authors.forename: D L
authors.initials: DL
authors.lastname: Sudan
authors.forename: J C
authors.initials: JC
authors.lastname: Anderson
authors.forename: J L
authors.initials: JL
authors.lastname: Wisecarver
authors.forename: S
authors.initials: S
authors.lastname: Balakrishnan
authors.forename: J L
authors.initials: JL
authors.lastname: Larsen
mesh_terms: D000328:Adult; D003923:Diabetes Mellitus, Lipoatrophic / Q000209:etiology* / Q000503:physiopathology; D005234:Fatty Liver / Q000150:complications*; D005260:Female; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D007333:Insulin Resistance; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000209:etiology / Q000473:pathology; D017093:Liver Failure / Q000209:etiology* / Q000601:surgery*; D016031:Liver Transplantation; D012008:Recurrence